Treatment of Irritable Bowel Syndrome with Modified TongXieYaoFang: A 83 Cases Study
10.3760/cma.j.issn.1673-4246.2009.05.028
- VernacularTitle:痛泻药方加减治疗腹泻型肠易激综合征83例
- Author:
Yuling SUN
;
Dengxian ZHAO
- Publication Type:Journal Article
- Keywords:
Irritable Bowel Syndrome: Traditional Chinese medicine;
TongXieYaoFang
- From:
International Journal of Traditional Chinese Medicine
2009;31(5):429-430
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the effects of treating irritable bowel syndrome (IBS) with modified TongXieYaoFang. Methods 83 IBS patients were randomly recruited into a treatment group (45 patients) and a control group (38 patients). In the control group, Trimebutine, 200mg, and Bifid triple viable capsule, 420mg, 3 times/day was given orally to the patients, while on the basis of that, the treatment group was administrated with modified TongXieYaoFang in addition. Both groups were treated for one course of 4 weeks. Results The total effective rate of the treatment group and the control group was 93.3% and 71.1% respectively, showing significant difference between the two groups (X2=7.2938, P<0.01 ). Conclusion TongXieYaoFang combined with western medicine is effective in treating IBS.